Profitability
Weight: 25%
C-
48
- 5yr Avg ROIC 3.1%
- Operating Margin Trend +5.13 pp/yr
BMRN
BioMarin Pharmaceutical Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
D
37
- 5yr Avg ROE 3.6%
- 5yr Share-Count CAGR 0.6%
Growth Quality
Weight: 25%
C
54
- 5yr Revenue CAGR 11.6%
- 5yr EPS CAGR -16.9%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
A-
83
- 5yr FCF Margin 10.8%
- 5yr FCF/NI Conversion 0.97x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -1.60x
- Interest Coverage (EBIT/Int) 45.27x
- Altman Z-Score 6.29
Stability
Weight: 5%
D+
41
- EPS Volatility (σ/μ) 0.75
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 5 gurus held; 2 added; 2 trimmed; 1 full exit.
- Holders
- 4 -1
- Avg Δ position
- -27.5%
- New buys
- 0
- Full exits
- 1
- Wood sold -100%
- Greenblatt decreased -84%
- Cooperman decreased -67%